125 related articles for article (PubMed ID: 10614662)
1. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo.
Shim WS; Conaway M; Masamura S; Yue W; Wang JP; Kmar R; Santen RJ
Endocrinology; 2000 Jan; 141(1):396-405. PubMed ID: 10614662
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.
Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ
Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496
[TBL] [Abstract][Full Text] [Related]
3. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.
Masamura S; Santner SJ; Heitjan DF; Santen RJ
J Clin Endocrinol Metab; 1995 Oct; 80(10):2918-25. PubMed ID: 7559875
[TBL] [Abstract][Full Text] [Related]
4. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.
Santen R; Jeng MH; Wang JP; Song R; Masamura S; McPherson R; Santner S; Yue W; Shim WS
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):115-25. PubMed ID: 11850215
[TBL] [Abstract][Full Text] [Related]
5. Adenosine monophosphate activated protein kinase (AMPK), a mediator of estradiol-induced apoptosis in long-term estrogen deprived breast cancer cells.
Chen H; Wang JP; Santen RJ; Yue W
Apoptosis; 2015 Jun; 20(6):821-30. PubMed ID: 25721362
[TBL] [Abstract][Full Text] [Related]
6. Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells.
Santen RJ; Lobenhofer EK; Afshari CA; Bao Y; Song RX
Breast Cancer Res Treat; 2005 Dec; 94(3):213-23. PubMed ID: 16258703
[TBL] [Abstract][Full Text] [Related]
7. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation.
Yue W; Wang JP; Hamilton CJ; Demers LM; Santen RJ
Cancer Res; 1998 Mar; 58(5):927-32. PubMed ID: 9500452
[TBL] [Abstract][Full Text] [Related]
8. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
[TBL] [Abstract][Full Text] [Related]
9. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells.
Jeng MH; Yue W; Eischeid A; Wang JP; Santen RJ
Breast Cancer Res Treat; 2000 Aug; 62(3):167-75. PubMed ID: 11072781
[TBL] [Abstract][Full Text] [Related]
10. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
[TBL] [Abstract][Full Text] [Related]
11. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol.
Song RX; Mor G; Naftolin F; McPherson RA; Song J; Zhang Z; Yue W; Wang J; Santen RJ
J Natl Cancer Inst; 2001 Nov; 93(22):1714-23. PubMed ID: 11717332
[TBL] [Abstract][Full Text] [Related]
13. Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer.
Santen RJ; Song RX; Zhang Z; Yue W; Kumar R
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):337S-45S. PubMed ID: 14734489
[TBL] [Abstract][Full Text] [Related]
14. Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells.
Song RX; Santen RJ; Kumar R; Adam L; Jeng MH; Masamura S; Yue W
Mol Cell Endocrinol; 2002 Jul; 193(1-2):29-42. PubMed ID: 12160999
[TBL] [Abstract][Full Text] [Related]
15. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations.
Ju YH; Allred KF; Allred CD; Helferich WG
Carcinogenesis; 2006 Jun; 27(6):1292-9. PubMed ID: 16537557
[TBL] [Abstract][Full Text] [Related]
16. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment.
Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Lawrence J; MacMahon LP; Yue W; Berstein L
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):155-65. PubMed ID: 16024245
[TBL] [Abstract][Full Text] [Related]
17. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
18. Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol.
Yue W; Wang JP; Conaway M; Masamura S; Li Y; Santen RJ
Endocrinology; 2002 Sep; 143(9):3221-9. PubMed ID: 12193533
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors: rationale for use following antiestrogen therapy.
Yue W; Santen RJ
Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
[TBL] [Abstract][Full Text] [Related]
20. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells.
Márquez DC; Pietras RJ
Oncogene; 2001 Sep; 20(39):5420-30. PubMed ID: 11571639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]